US Broker Ratings

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Is a 39% Upside Within Reach?

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, is capturing investor attention with a potential upside of 39.39% according to analysts’ average target price. With a..

Gilead Sciences, Inc. (GILD) Stock Analysis: Navigating Healthcare Innovation with a 3.04% Upside Potential

Investors eyeing Gilead Sciences, Inc. (NASDAQ: GILD) may find the biopharmaceutical giant’s current market trajectory compelling. With a market capitalization of $139.89 billion, Gilead is a stalwart in the healthcare..

Medtronic plc (MDT) Stock Analysis: Evaluating the 9.14% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a titan in the healthcare sector, remains a focal point for investors eyeing opportunities within the medical devices industry. Headquartered in Galway, Ireland, Medtronic’s expansive market..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Closer Look at the 11% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading player in the biotechnology sector, has been at the forefront of developing therapies for cystic fibrosis (CF), among other medical conditions. With a..

Novo Nordisk A/S (NVO) Stock Analysis: Exploring Its Robust Growth and 22.79% Upside Potential

Novo Nordisk A/S (NYSE: NVO), headquartered in Bagsvaerd, Denmark, is a prominent player in the healthcare sector, specifically within the drug manufacturing industry. With a staggering market cap of $334.5..

DexCom, Inc. (DXCM) Stock Analysis: Analyst Consensus Points to 13.59% Potential Upside

DexCom, Inc. (DXCM), a prominent player in the healthcare sector, particularly within the medical devices industry, continues to attract attention from individual investors and analysts alike. With a market capitalization..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating a Promising 10% Potential Upside for Investors

AbbVie Inc. (NYSE: ABBV), a formidable player in the healthcare sector, continues to capture investor interest as it navigates the dynamic landscape of the pharmaceutical industry. With a market capitalization..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Biotech Innovator with a 6.58% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a prominent player in the biotechnology sector, making significant strides in developing therapeutics based on ribonucleic acid interference (RNAi). With a market capitalization..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with 6% Upside Potential

McKesson Corporation (NYSE: MCK) stands tall as a pillar in the healthcare sector, primarily operating within the medical distribution industry. With a robust market capitalization of $89.11 billion, the company..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings and Promising 5.41% Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust portfolio spanning medical devices, diagnostics, pharmaceuticals, and nutritional products. Headquartered..

Edwards Lifesciences Corporatio (EW)

⚠️ No article content returned.

..

Stryker Corporation (SYK) Investor Outlook: Navigating a 9.79% Potential Upside in Medical Devices

Stryker Corporation (NYSE: SYK) stands as a formidable player in the healthcare sector, prominently known for its innovation in medical devices. With a robust market capitalization of $146.71 billion, Stryker..

Sanofi (SNY) Investor Outlook: Potential 27% Upside Amid Robust Dividend Yield

Sanofi (NYSE: SNY), a titan in the healthcare sector, continues to capture investor attention with its promising outlook and substantial dividend yield. Headquartered in Paris, France, Sanofi operates globally, providing..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Navigating 19.2% Revenue Growth and Future Prospects

Investors eyeing the healthcare sector might find Intuitive Surgical, Inc. (NASDAQ: ISRG) an intriguing proposition, given its substantial $199.67 billion market cap and impressive 19.2% revenue growth. The company, renowned..

Elevance Health, Inc. (ELV) Stock Analysis: Unpacking a 27% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans sector, is drawing attention from investors with a substantial market capitalization of $88.87 billion. This health benefits company, previously..

Danaher Corporation (DHR) Stock Analysis: Uncovering a 26% Upside Potential Amidst Healthcare Dominance

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, has consistently commanded investor attention with its robust portfolio spanning biotechnology, life sciences, and diagnostics. With a market capitalization of..

AstraZeneca PLC (AZN) Stock Analysis: Exploring a 15.51% Potential Upside with Strong Buy Ratings

AstraZeneca PLC (NASDAQ: AZN), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio of prescription medicines and strategic innovations. With a market capitalization of..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a Potential 215% Upside in Biotech

MBX Biosciences, Inc. (NASDAQ: MBX) is capturing significant attention in the biotechnology sector, particularly among investors seeking high-growth opportunities in the healthcare industry. The company, based in Carmel, Indiana, was..

PureTech Health plc (PRTC) Stock Analysis: Unveiling a 183% Potential Upside in Biotech Innovation

PureTech Health plc (NASDAQ: PRTC), a burgeoning entity in the biotechnology sector, is capturing the attention of investors with its remarkable potential upside of 183.24%. With a focus on developing..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Potential 379.95% Upside in the Biotech Sector

For investors with a keen eye on the healthcare sector, Prothena Corporation plc (PRTA) offers a compelling opportunity within the biotechnology industry. Based in Dublin, Ireland, Prothena is a late-stage..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds